---
title: Posterior Pituitary
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Huppert's Notes]]

# Posterior Pituitary #ðŸš§ æ–½å·¥ä¸­

### Posterior Pituitary

##### â†“Antidiuretic hormone (ADH): Diabetes insipidus (DI)

â€¢Â Â Â Etiology: ADH channels do not function to reabsorb water, either due to inadequate ADH (central) or lack of response to ADH at the kidneys (nephrogenic)

-Â Â Â **Central DI:**

**â€¢**Â Â Â Low posterior pituitary production of ADH

**â€¢**Â Â Â Etiologies: Idiopathic (~50% of cases in adults), acquired (trauma/surgery, neoplasms, infiltrative/infectious \[Langerhans, sarcoidosis, tuberculosis\], vascular), congenital malformations, genetic

-Â Â Â **Nephrogenic DI:**

**â€¢**Â Â Â Normal ADH production but the renal tubules do not respond to ADH appropriately

**â€¢**Â Â Â Etiologies: Medications (lithium, cisplatin), metabolic (hypercalcemia, hypokalemia), ureteral obstruction

â€¢Â Â Â Clinical features: Polyuria (>3 liters urine output in 24 hours), polydipsia. High serum osms, low urine osms

â€¢Â Â Â Diagnosis:

-Â Â Â Confirm polyuria with 24-hr urine volume (typically >3 L/day); urine is typically hypotonic (<300 mosm/kg); exclude glucosuria as cause

-Â Â Â Differentiate between primary polydipsia (excessive fluid intake) and DI: history, serum sodium, and plasma osms can be helpful. Further testing that can be considered:

**â€¢**Â Â Â Water deprivation test: Withhold fluids and measure urine osmolality (should follow strict protocol with weights, urine osm, and endocrine input): Increase in UOsm = primary polydipsia. Stable = DI.

**â€¢**Â Â Â Hypertonic saline infusion test

**â€¢**Â Â Â Plasma copeptin proAVP (CPAVP) measurement

-Â Â Â Differentiate between central and nephrogenic DI:

**â€¢**Â Â Â ADH (desmopressin) challenge: Increase UOsm >50% = Central DI. Stable = Nephrogenic DI.

â€¢Â Â Â Treatment:

-Â Â Â Central DI: Desmopressin (DDAVP), chlorpropamide increase ADH secretion and enhances effect

-Â Â Â Nephrogenic DI: No good treatments. Sodium restriction and thiazide diuretics can be useful.

-Â Â Â Pearl: Patients with central DI who donâ€™t have access to water and are hospitalized can develop severe hypernatremia. While hospitalized, monitor strict intake/output.

##### â†‘ADH: Syndrome of inappropriate ADH (SIADH)/syndrome of inappropriate antidiuresis (SIAD)

â€¢Â Â Â Etiology: Ectopic production of ADH by a tumor (e.g., small cell lung cancer), CNS trauma, pulmonary infection, medications (e.g., SSRIs, chlorpropamide, oxytocin, morphine, vincristine, desmopressin), postoperatively

â€¢Â Â Â Clinical features:

-Â Â Â Low serum Na\+ and osms because retain free water; normal or high urine sodium and osms

-Â Â Â Acute symptoms: Lethargy, somnolence, seizures, coma, death

â€¢Â Â Â Diagnosis: Check serum/urine sodium and osms. Rule out other causes of hyponatremia â€“ SIADH is a diagnosis of exclusion.

â€¢Â Â Â Treatment:

-Â Â Â Fluid restriction is the mainstay of treatment in most cases

-Â Â Â Central: Consider desmopressin

-Â Â Â Peripheral: Consider thiazide diuretic

-Â Â Â Lithium-induced: Stop lithium if possible

